A Lox/CHOP-10 Crosstalk Governs Osteogenic and Adipogenic Cell Fate by MSCs

Wen-yan Jiang,Chun Xing,Hong-wei Wang,Wei Wang,Su-zhen Chen,Liu-fang Ning,Xu,Qi-qun Tang,Hai-yan Huang
DOI: https://doi.org/10.1111/jcmm.13798
2018-01-01
Journal of Cellular and Molecular Medicine
Abstract:Accelerated marrow adipogenesis has been associated with ageing and osteoporosis and is thought to be because of an imbalance between adipogenic and osteogenic differentiation of mesenchymal stem cell (MSCs). We have previously found that lysyl oxidase (Lox) inhibition disrupts BMP4-induced adipocytic lineage commitment and differentiation of MSCs. In this study, we found that lox inhibition dramatically up-regulates BMP4-induced expression of CCAAT/enhancer binding protein (C/EBP) homologous protein 10 (CHOP-10), which then promotes BMP4-induced osteogenesis of MSCs both in vitro and in vivo. Specifically, Lox inhibition or CHOP-10 up-regulation activated Wnt/beta-catenin signalling to enhance BMP4-induced osteogenesis, with pro-adipogenic p38 MAPK and Smad signalling suppressed. Together, we demonstrate that Lox/CHOP-10 crosstalk regulates BMP4-induced osteogenic and adipogenic fate determination of MSCs, presenting a promising therapeutic target for osteoporosis and other bone diseases.
What problem does this paper attempt to address?